Mutual Fund Ownership
ARK Genomic Revolution ETF is the biggest individual fund holder of Prime Medicine, Inc. Common Stock (PRME), owning a total of 1.3 million shares. Combined, the top 19 mutual fund holders of PRME own 2.93% of the company with a total of 2.8 million shares.
In the latest ownership report on October 31st 2022, the top 19 fund holders increased their combined ownership of PRME by 1.5 million shares. 16 funds bought 1,506,046 total additional shares and increased their ownership by an average of 0.00%. However 1 funds sold 1,800 total shares and decreased their ownership by an average of 0.14%.
Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Prime Medicine, Inc. Common Stock increased by a net total of 1,504,246 in the latest report.